The following list shows A4's recent advocacy. This list contains both publications (including briefs and submissions) and communications (letters & emails).

To find a (free) disability advocate to help you, try:

2/6/2011 response from Mental Health Minister

By convenor |

In response to our letter in April 2011, A4 received the (completely unsatisfactory and inappropriate) response below from the Ministerial Liaison and Support Section of the Department of Health and Ageing.

This completely missed the point that A4 asked that a submission be considered for the Budget ... the opportunity is now well past.

Report - Economic Costs of Autism Spectrum Disorder in Australia

By bobb |

Key findings 

This review has produced an estimate of the annual economic costs of Autism Spectrum Disorder (ASD) in Australia, updating a previous study completed in April 2007. 

This review has produced an updated estimate of the annual economic costs of ASD in Australia, including the burden of disease, of between $8.1 billion (low prevalence) and $11.2 billion (high prevalence), with a mid-point of $9.7 billion (all estimates are in December 2010 dollars). 

Half of All Children with Autism Wander into Danger

By bobb |

Wandering is a critical safety issue for children with ASD.

The Interactive Autism Network (IAN), www.ianproject.org, the nation's largest online autism research project, reported this week the preliminary results of the first major survey on wandering among individuals with autism spectrum disorders (ASD).

Approximately half of 800 parents who completed the survey reported that their child leaves safe places, with the behavior peaking at age four. Among these families, nearly half say that their child has gone missing long enough to cause significant concern about safety.

Autism and Self Advocacy

By bobb |

By John Elder Robison

What, exactly, is self-advocacy and what is its place in the autism community?

Autism is a communication disorder, with a broad range of affect. Some people's autism makes them eccentric and geeky. Other people can't speak at all, as a result of more severe autistic disability.

Business Council of Australia gives simplistic and morally bankrupt advice

By convenor |

Media Release

Autism Asperger Advocacy Australia (A4) calls on the Treasurer, Mr Swan, to ignore the Business Council of Australia’s simplistic and morally bankrupt advice on Disability Support Pensions. The Business Council of Australia (BCA) is calling for cuts to disability support.

In a letter to the Treasurer, Bob Buckley, A4’s Convenor, says “the views of the BCA on this issue are not based on facts and are economically unsound. BCA members, Australia’s top 100 companies, should be embarrassed.”

The economic value of informal care in 2010

By convenor |

The foreword to this report says "the value of informal care has increased to exceed $40 billion per annum in 2010, 33% higher than in 2005". It says this is based on $31 per hour replacement costs. Probably, some of the value is estimated based on conjugate/centre-based care - so better care would be more expensive.

This report is not autism/ASD specific ... but is contains valuable and relevant material.

Alternative Biomedical Treatments for Autism: How Good Is the Evidence?

By bobb |

Research on only one treatment is rigorous enough to earn an A grade



Image: Photograph by Joi, courtesy Flickr

By Nancy Shute October 7, 2010

Parents who research treatments for autism are confronted with a bewildering array of options, almost all of which have never been tested for safety and effectiveness. Organizations like The Cochrane Collaboration, which reviews the quality of evidence for medical treatments, are putting more effort into evaluating popular alternative treatments.

So far, the most comprehensive review of alternative autism treatments comes from two pediatricians: Susan Hyman of the University of Rochester School of Medicine Golisano Children's Hospital at Strong and Susan Levy, a clinical professor of pediatrics at the University of Pennsylvania School of Medicine and The Children's Hospital of Philadelphia. Their 2008 analysis gave each treatment a letter grade for the quality of the research conducted up to that point; the mark, however, is not a ranking of the treatment's safety or effectiveness.